Sinopharm-developed COVID-19 drugs to finish clinical study within a year
CGTN, 09 Nov 2021
For more:
https://news.cgtn.com/news/2021-11-09/Sinopharm-developed-COVID-19-drugs-to-finish-clinical-study-in-a-year-153x0Xr5Ozm/index.html
Two years into the pandemic, life has seen drastic changes. The death rate from overall COVID-19 infections has reached 2 percent. And pharmaceutical companies around the world are already working on drugs to combat the virus, with some making significant progress. CGTN's Liu Jiaxin talked to Zhang Yuntao, vice-president and chief scientist of the China National Biotech Group (CNBG), who shared the latest updates on China's progress toward an antiviral COVID-19 pill.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
https://news.cgtn.com/news/2021-11-09/Sinopharm-developed-COVID-19-drugs-to-finish-clinical-study-in-a-year-153x0Xr5Ozm/index.html
Two years into the pandemic, life has seen drastic changes. The death rate from overall COVID-19 infections has reached 2 percent. And pharmaceutical companies around the world are already working on drugs to combat the virus, with some making significant progress. CGTN's Liu Jiaxin talked to Zhang Yuntao, vice-president and chief scientist of the China National Biotech Group (CNBG), who shared the latest updates on China's progress toward an antiviral COVID-19 pill.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
